Skip to content

New-Fill recommended for approval in US as Sculptra (amended)

Abnormal vaginal Pap smears common in HIV-positive women after hysterectomy

HIV-specific immune responses key to speed of disease progression

Microbicides pose new challenges for design of research studies

Microbicides 2004 marks new wave of HIV prevention trials

HIV infection changes the genes that affect development of tuberculosis

ARV-based HIV microbicides advanced by ground-breaking partnership

Rectal HIV microbicides still a distant prospect

Multicentre UK HIV cohort involving over 13,000 patients established